Contemporary Diagnosis, Management, and Early Outcomes in Children with Kawasaki Disease in Romania: A Single-Center

Cristina Ramona Rădulescu1,2, Anca Cristina Drăgănescu1,2, Diana Maria Băncilă1,2

  • 1Department of Pediatrics, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

PubMed

Insights

Kawasaki disease (KD) is a serious inflammatory condition in children. This study of Romanian children shows favorable outcomes with standard IVIG and aspirin treatment, with minimal cardiac complications.

Area of Science:

  • Pediatrics
  • Cardiology
  • Rheumatology

Background:

  • Kawasaki disease (KD) is an acute inflammatory vasculitis.
  • It is a leading cause of acquired heart disease in children and young adults.
  • Coronary artery complications are a significant concern in KD.

Purpose of the Study:

  • To analyze the diagnostic process, therapeutic strategies, and early outcomes of Kawasaki disease in Romania.
  • To present the largest contemporary Romanian cohort of KD patients.
  • To evaluate cardiovascular complications and treatment responses.

Main Methods:

  • Retrospective analysis of patients aged 0-18 years hospitalized between 2018-2023.
  • Data collected on clinical presentation, treatment, and echocardiographic findings.
  • Standard treatment protocols including intravenous immunoglobulin (IVIG) and acetylsalicylic acid were followed.

Main Results:

  • 25 children diagnosed with KD; mean age 2.9 years, 56% boys.
  • Fever ≥5 days and oral changes were most frequent symptoms.
  • 100% received IVIG, 68% acetylsalicylic acid; 2 cases IVIG-resistant.
  • Mild coronary artery dilatation (21.7%), mild valvular regurgitation, and small pericardial effusion noted.
  • Infants showed less inflammation but higher leukocytosis and longer hospital stays.
  • 92% discharged favorably, no deaths recorded.

Conclusions:

  • This study represents the largest contemporary Romanian cohort of Kawasaki disease.
  • Standard treatment protocols yielded favorable early outcomes with low rates of cardiac complications.
  • The findings outline local diagnostic and therapeutic approaches for KD in Romania.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
360
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
544
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
484
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
842